SCHEMBL17675101

SCHEMBL17675101

CC(C)(C)c1ccc(C[C@H](N)C(=O)O)c(C(C)(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 3/20 0.46
▸ USP2 O75604 3/20 0.45
▸ PKM P14618 2/20 0.45
▸ ALOX15 P16050 2/20 0.45
▸ HIF1A Q16665 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ RECQL P46063 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ RGS12 O14924 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ BRCA1 P38398 1/20 0.45
▸ THPO P40225 1/20 0.45
▸ CASP7 P55210 1/20 0.45
▸ GNAI1 P63096 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27535126 0.85 ALOX15 (0.51) USP2PKMALOX15HIF1AHSD17B10
SCHEMBL9513810 0.85 ALOX15 (0.51) USP2PKMALOX15HIF1AHSD17B10
SCHEMBL6584398 0.85 ALOX15 (0.51) USP2PKMALOX15HIF1AHSD17B10
SCHEMBL8525825 0.83 ATM (0.36) KIF11MEN1ALDH1A1LMNAKMT2A
SCHEMBL23581846 0.80 NOS3 (0.55) KIF11USP2PKMALOX15HIF1A
SCHEMBL1312888 0.79 GRB2 (0.54) KIF11USP2PKMALOX15HIF1A
SCHEMBL1312890 0.79 GRB2 (0.54) KIF11USP2PKMALOX15HIF1A
SCHEMBL7271154 0.78 KDM4E (0.65) USP2PKMALOX15HIF1AHSD17B10
SCHEMBL5324072 0.78 KDM4E (0.65) USP2PKMALOX15HIF1AHSD17B10
SCHEMBL9122555 0.77 PTPN1 (0.43) KIF11USP2PKMALOX15HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2017-08-16 — — EP disclosed
WO-2016057572-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MILLER MARK THOMAS (US) 2016-04-14 — — WO disclosed
Send feedback